Skip to main content

Want a detailed portfolio tracker?

Werewolf Therapeutics (HOWL) P/E (2021 - 2026)

Werewolf Therapeutics (HOWL) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Werewolf Therapeutics (HOWL) P/E is -0.30. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Werewolf Therapeutics (HOWL)

YearP/EChange
2026-0.30-36.69%
2025-0.48-47.91%
2024-0.92-73.86%
2023-3.53+264.77%
2022-0.97-87.31%
2021-7.62N/A

Comparison Werewolf Therapeutics (HOWL) P/E with competitors

Werewolf Therapeutics (HOWL) P/E is -0.30.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.56%
NBYStablecoin Development Corp0.00-101.41%
ENLVEnlivex Ltd0.07-124.60%
FGENFibroGen Inc0.24-178.94%
CHRSCoherus Biosciences Inc0.85-379.03%
FBIOFortress Biotech Inc0.95-412.08%
ORMPOramed Pharmaceuticals Inc1.50-594.27%
AGENAgenus Inc3.01-1089.68%
INVAInnoviva Inc3.15-1137.17%
VXRTVaxart Inc3.55-1267.30%
CRMDCorMedix Inc3.63-1293.18%
CVACCureVac N.V.4.45-1561.91%
GLPGGalapagos NV4.86-1697.80%
SRPTSarepta Therapeutics Inc4.88-1705.43%
ABEOAbeona Therapeutics Inc5.39-1871.63%
ABUSArbutus Biopharma Corp5.60-1940.06%
ZVRAZevra Therapeutics Inc5.89-2035.95%
SPROSpero Therapeutics Inc6.23-2148.16%
CGENCompugen Ltd6.31-2176.28%
RIGLRigel Pharmaceuticals6.87-2359.81%
SLXNSilexion Therapeutics Corp7.30-2499.24%
OMEROmeros Corporation9.26-3144.65%
AUPHAurinia Pharmaceuticals Inc9.58-3251.92%
PLXProtalix BioTherapeutics Inc10.89-3681.40%
ACADAcadia Pharmaceuticals Inc11.73-3956.82%
TBPHTheravance Biopharma Inc12.26-4132.29%
ADMAAdma Biologics Inc12.42-4183.59%
SABSSAB Biotherapeutics Inc14.14-4748.56%
NAGENiagen Bioscience Inc14.82-4972.81%
INCYIncyte Corp15.82-5303.11%
REGNRegeneron Pharmaceuticals Inc15.86-5314.32%
PBYIPuma Biotechnology Inc17.32-5794.11%
CPRXCatalyst Pharmaceuticals Inc17.44-5834.76%
EXELExelixis Inc17.54-5867.22%
TGTXTG Therapeutics Inc18.97-6336.82%
MDXGMimedx Group Inc20.55-6858.51%
XOMAXOMA Royalty Corp22.87-7622.34%
ARGXArgen X SE24.30-8090.39%
CTMXCytomX Therapeutics Inc24.82-8262.42%
XOMAOXOMA Royalty Corp25.34-8434.64%
HALOHalozyme Therapeutics Inc25.62-8526.35%
XOMAPXOMA Royalty Corp25.67-8541.61%
VRTXVertex Pharmaceuticals Inc27.99-9306.06%
RPRXRoyalty Pharma plc - Class A28.69-9533.89%
SLNOSoleno Therapeutics Inc29.02-9641.69%
ASNDAscendis Pharma A/S30.09-9993.63%
LGNDLigand Pharmaceuticals Inc - Class B37.91-12567.36%
APLSApellis Pharmaceuticals Inc39.02-12932.12%
BMRNBiomarin Pharmaceutical Inc42.21-13981.36%
KRYSKrystal Biotech Inc45.34-15011.19%
ONCBeiGene Ltd69.54-22968.37%
PHARPharming Group N.V.75.03-24772.16%
TECHBio-Techne Corp101.96-33629.02%
VCELVericel Corp109.92-36247.64%
ALNYAlnylam Pharmaceuticals Inc117.96-38892.83%
GMABGenmab140.29-46234.63%
TLXTelix Pharmaceuticals Ltd162.15-53423.97%
CORTCorcept Therapeutics Inc212.86-70098.21%